Status:
COMPLETED
Dose-Exposure-Response in Type 1 Diabetes Mellitus
Lead Sponsor:
Sanofi
Conditions:
Diabetes Mellitus, Type I
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
To investigate the dose-exposure-response relationship of insulin glulisine (HMR1964) after single subcutaneous injections of 0.075, 0.15 and 0.3 U/kg body weight with the euglycaemic clamp technique ...
Eligibility Criteria
Inclusion
- Type 1 diabetes mellitus
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00368394
Start Date
January 1 2004
Last Update
August 24 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-Aventis
Neuss, Germany